chr17-27798892-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000313735.11(NOS2):c.-73-10C>T variant causes a splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.346 in 886,886 control chromosomes in the GnomAD database, including 53,564 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.34 ( 8780 hom., cov: 31)
Exomes 𝑓: 0.35 ( 44784 hom. )
Consequence
NOS2
ENST00000313735.11 splice_polypyrimidine_tract, intron
ENST00000313735.11 splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.0001112
2
Clinical Significance
Conservation
PhyloP100: 0.663
Genes affected
NOS2 (HGNC:7873): (nitric oxide synthase 2) Nitric oxide is a reactive free radical which acts as a biologic mediator in several processes, including neurotransmission and antimicrobial and antitumoral activities. This gene encodes a nitric oxide synthase which is expressed in liver and is inducible by a combination of lipopolysaccharide and certain cytokines. Three related pseudogenes are located within the Smith-Magenis syndrome region on chromosome 17. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 17-27798892-G-A is Benign according to our data. Variant chr17-27798892-G-A is described in ClinVar as [Benign]. Clinvar id is 2688120.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.408 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NOS2 | NM_000625.4 | c.-73-10C>T | splice_polypyrimidine_tract_variant, intron_variant | ENST00000313735.11 | NP_000616.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NOS2 | ENST00000313735.11 | c.-73-10C>T | splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_000625.4 | ENSP00000327251 | P2 | |||
NOS2 | ENST00000697337.1 | upstream_gene_variant | ENSP00000513259 |
Frequencies
GnomAD3 genomes AF: 0.336 AC: 51076AN: 151856Hom.: 8777 Cov.: 31
GnomAD3 genomes
AF:
AC:
51076
AN:
151856
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.367 AC: 76702AN: 209188Hom.: 14076 AF XY: 0.366 AC XY: 41041AN XY: 112206
GnomAD3 exomes
AF:
AC:
76702
AN:
209188
Hom.:
AF XY:
AC XY:
41041
AN XY:
112206
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.348 AC: 255688AN: 734912Hom.: 44784 Cov.: 10 AF XY: 0.350 AC XY: 136515AN XY: 390148
GnomAD4 exome
AF:
AC:
255688
AN:
734912
Hom.:
Cov.:
10
AF XY:
AC XY:
136515
AN XY:
390148
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.336 AC: 51116AN: 151974Hom.: 8780 Cov.: 31 AF XY: 0.341 AC XY: 25320AN XY: 74288
GnomAD4 genome
AF:
AC:
51116
AN:
151974
Hom.:
Cov.:
31
AF XY:
AC XY:
25320
AN XY:
74288
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1302
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 51% of patients studied by a panel of primary immunodeficiencies. Number of patients: 48. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at